Hand sanitisers for reducing illness absences in primary school children in New Zealand: a cluster randomised controlled trial study protocol.
BACKGROUND
New Zealand has relatively high rates of morbidity and mortality from infectious disease compared with other OECD countries, with infectious disease being more prevalent in children compared with others in the population. Consequences of infectious disease in children may have significant economic and social impact beyond the direct effects of the disease on the health of the child; including absence from school, transmission of infectious disease to other pupils, staff, and family members, and time off work for parents/guardians. Reduction of the transmission of infectious disease between children at schools could be an effective way of reducing the community incidence of infectious disease. Alcohol based no-rinse hand sanitisers provide an alternative hand cleaning technology, for which there is some evidence that they may be effective in achieving this. However, very few studies have investigated the effectiveness of hand sanitisers, and importantly, the potential wider economic implications of this intervention have not been established.


OBJECTIVE
The primary objective of this trial is to establish if the provision of hand sanitisers in primary schools in the South Island of New Zealand, in addition to an education session on hand hygiene, reduces the incidence rate of absence episodes due to illness in children. In addition, the trial will establish the cost-effectiveness and conduct a cost-benefit analysis of the intervention in this setting.


METHODS
A cluster randomised controlled trial will be undertaken to establish the effectiveness and cost-effectiveness of hand sanitisers. Sixty-eight primary schools will be recruited from three regions in the South Island of New Zealand. The schools will be randomised, within region, to receive hand sanitisers and an education session on hand hygiene, or an education session on hand hygiene alone. Fifty pupils from each school in years 1 to 6 (generally aged from 5 to 11 years) will be randomly selected for detailed follow-up about their illness absences, providing a total of 3400 pupils. In addition, absence information will be collected on all children from the school rolls. Investigators not involved in the running of the trial, outcome assessors, and the statistician will be blinded to the group allocation until the analysis is completed.


BACKGROUND
ACTRN12609000478213.
McKenzie
Joanne E
JE
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. joanne.mckenzie@med.monash.edu.au
Priest
Patricia
P
Audas
Rick
R
Poore
Marion R
MR
Brunton
Cheryl R
CR
Reeves
Lesley M
LM
D000041:Absenteeism; D000279:Administration, Cutaneous; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage* / Q000191:economics; D002648:Child; D016000:Cluster Analysis; D003140:Communicable Disease Control / Q000191:economics / Q000379:methods*; D003141:Communicable Diseases / Q000191:economics / Q000635:transmission*; D003362:Cost-Benefit Analysis; D006235:Hand Disinfection; D006801:Humans; D009520:New Zealand; D012107:Research Design; D012572:School Health Services / Q000191:economics; D012574:Schools / Q000191:economics; D013334:Students
D000891:Anti-Infective Agents, Local